Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of drugs designed to exploit specific genetic mutations in cancer cells. PARP is an enzyme that helps repair DNA damage in cells. By inhibiting PARP, these drugs prevent cancer cells from repairing their DNA, leading to cell death, particularly in cells already compromised by genetic defects.
